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Abstract
Estimation of risk of recurrence in early-stage oral tongue squamous cell carcinoma (OTSCC) remains a challenge in the field of
head and neck oncology.We examined the use of artificial neural networks (ANNs) to predict recurrences in early-stage OTSCC.
A Web-based tool available for public use was also developed. A feedforward neural network was trained for prediction of
locoregional recurrences in early OTSCC. The trained network was used to evaluate several prognostic parameters (age, gender,
T stage, WHO histologic grade, depth of invasion, tumor budding, worst pattern of invasion, perineural invasion, and lympho-
cytic host response). Our neural network model identified tumor budding and depth of invasion as the most important prognos-
ticators to predict locoregional recurrence. The accuracy of the neural network was 92.7%, which was higher than that of the
logistic regression model (86.5%). Our online tool provided 88.2% accuracy, 71.2% sensitivity, and 98.9% specificity. In
conclusion, ANN seems to offer a unique decision-making support predicting recurrences and thus adding value for the man-
agement of early OTSCC. To the best of our knowledge, this is the first study that applied ANN for prediction of recurrence in
early OTSCC and provided a Web-based tool.
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Introduction
Oral tongue squamous cell carcinoma (OTSCC) typically dis-
plays aggressive behavior even at an early stage [1, 2].
Inaccurate assessment of OTSCC behavior may lead to im-
proper management either as ineffective treatment or as unnec-
essary overtreatment. Therefore, identifying patients with low-
risk or high-risk OTSCC can influence management decision-
making and guide the selection of treatment approach. Several
prognostic markers have been suggested to improve the prog-
nostication of OTSCC [3, 4]. The advantages of evaluating
some histopathologic prognostic markers in the examination
of routine hematoxylin and eosin (HE)-stained slides include
their low cost and time-saving aspects (as there is no need for
additional staining) as well as the fact that these markers are
potentially ready to be included in the routine pathology re-
ports. Such advantages have motivated researchers to study
various histopathologic features, and the recent evidence has
confirmed the prognostic value of certain markers including,
for example, tumor budding [5], depth of invasion [6], worst
pattern of invasion [7], and perineural invasion [8]. It is neces-
sary to mention that the previous studies on these markers have
used traditional tools for data analysis, which have not pro-
duced any simple approach to utilize them as multiple prognos-
tic factors should be applied to aid decision making.
The use of machine learning, a branch of artificial intelli-
gence, in medical applications has increased widely in recent
years; this has been driven by the rapidly accumulating vol-
ume of medical data. Similarly, artificial neural networks
(ANNs) are an integral part and a subfield of machine learn-
ing. An ANN is an innovative hardware/software model that
functions in a way inspired by the human brain [9–12]. In
addition, ANN seems effective since the complex relationship
between input and output can be accurately modeled with a
relatively simple computer programming code. Structurally,
ANN comprises input, hidden, and output layers (Fig. 1).
ANNs have an effective learning ability, and they can learn
the relationship within a dataset. This effective learning char-
acteristic has made ANN a good choice for predictive infer-
ences that can be used to provide support for clinical decision-
making. Many recent studies have applied ANNs for the prog-
nostication of different cancers [9–12]. ANNs are adapted sta-
tistical models that analyze data for the prediction of outcomes
in medical applications [13, 14], such as in colorectal cancer
[15] and acute pancreatitis [16]. Spelt and collaborators applied
ANN to predict survival in colorectal cancer, revealing that
ANN produces better C-index than Cox regression [17].
The use of ANNs specifically for early OTSCC has not
been previously studied. Thus, this study examined the use
of ANN in prognostication of early OTSCC. We examined
the use of ANNs to estimate the risk of locoregional recur-
rence in early-stage OTSCC. The neural network toolbox of
MATLAB (R2018b version) was used to create, train, and
simulate ANN for pattern recognition and classification [18].
Furthermore, the Microsoft Azure machine learning studio
(Azure, 2018) was used to develop a Web-based prognostic
estimator that can provide a prediction for each individual case
in daily practice.
Material and methods
Patients
The clinicopathologic characteristics of 311 patients
with cT1-2cN0cM0 OTSCC treated between 1979 and
2009 at the University Hospitals of Helsinki, Oulu,
Turku, Tampere, and Kuopio (all in Finland) and at
the A.C. Camargo Cancer Center in Sao Paulo, Brazil,
were collected. The histopathologic parameters are brief-
ly summarized in Table 1. The use of patient samples
and data inquiry in this study were approved by the
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Fig. 1 Structure of ANN with prognostic factors for training the network (WPOI worst pattern of invasion, LHR lymphocytic host response, PNI
perineural invasion)
Finnish National Supervisory Authority for Welfare and
Health (VALVIRA), and by the Ethics Committee in
Research of the Piracicaba Dental School, University
of Campinas, São Paulo, Brazil.
Prognostic parameters
Clinicopathologic variables including age, gender, T
stage (AJCC 7th), and WHO grade were included as
classic prognostic factors. All histopathologic parameters
were evaluated on postoperative surgical specimens
stained with routine hematoxylin and eosin. The histo-
pathologic parameters include the WHO histological
grade, tumor budding, depth of invasion, worst pattern
of invasion (WPOI), lymphocytic host response (LHR),
and perineural invasion (PNI). We selected these prog-
nostic factors based on our recent reports on the signif-
icance of tumor budding [19, 20], depth of invasion,
and worst pattern of invasion in early OTSCC [7]. Of
note, a recent study on a large cohort of OSCC [21]
underlined the prognostic significance of all the prog-
nostic factors that we used to construct the ANN.
ANN for prediction of locoregional recurrence
The dataset of 311 cases was loaded into the MATLAB
workspace (The MathWorks, Inc., USA). An example of a
feedforward neural network used was the basic feedforward net-
work also known as multi-layer perceptron (MLP), with sigmoid
hidden and softmax output activation function [22]. It is a two-
layer network where the training of the network is based on the
definition of a suitable error function, which is optimized with
respect to the weights and biases in the network [22].
Prediction of locoregional recurrence
A supervised learning method was used in this study. After
loading the dataset into the MATLAB workspace, prognostic
factors including age, gender, stage, WHO histologic grade,
tumor budding, tumor depth, WPOI, LHR, and PNI were set
as inputs for the neural network, and locoregional recurrence
was considered as the output. The neural network representa-
tion of the inputs, hidden neurons, and the outputs of the
training process is shown in Fig. 1.
The dataset is usually divided into 70% training, 15% val-
idation, and 15% testing sets [18, 23, 24]. In some instances,
the validation and testing sets can be combined and consid-
ered to be testing sets only. This was the case with the Azure
machine learning studio [25]. The prediction of locoregional
recurrence was thought to be a classification task which is a
form of pattern recognition. Therefore, the network was
trained using patternnet function. It creates a standard solution
neural network that classifies inputs into a target. The final
process involves training the configured network for predic-
tion [26, 27]. Follow-up time and disease-free time were in-
cluded in the training of the network. The network was trained
using scaled conjugate gradient backpropagation and the per-
formance of the network was computed using cross-entropy as
Table 1 Summary of
histopathologic parameters
included for neural network
analysis and development of the
Web-based tool
Variable Categories Definition Total Recurrence
WHO grade
Grade I Well-differentiated tumor 105 28
Grade II Moderately differentiated tumor 131 38
Grade III Poorly differentiated tumor 75 23
Tumor budding*
None There is no tumor budding 114 26
Low Tumor has less than five buds 102 24
High Tumor has five buds or more at the invasive front 95 39
Depth of invasion
Superficial Tumor less than 4 mm in depth 116 26
Deep Tumor with 4 mm in depth or deeper 195 63
Worst pattern of invasion (WPOI)
Type 1; Type 2; Type 3** Pushing border; finger-like growth; large tumor islands 78 15
Type 4 Small tumor islands (≤ 15 cancer cells) 190 61
Type 5 Tumor satellites 43 13
Lymphocytic host response (LHR)
Type 1 Strong 53 16
Type 2 Intermediate 116 35
Type 3 Weak 142 38
Perineural invasion (PNI)
Absent PNI was not observed 269 73
Present PNI was observed 42 16
*Tumor budding defined as a single cancer cell or cancer cluster of four cancer cells or less
**Types 1, 2, and 3 of worst pattern of invasion were considered in one risk group
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shown in Fig. 2. The overall performance of this trained net-
work was measured in terms of accuracy and area under re-
ceiving characteristic curve. Additionally, we compared the
performance of this ANNmodel with logistic regression mod-
el in terms of accuracy.
Analyses of the importance of prognostic parameters
To examine the importance of each of the prognostic factors,
each factor was removed from the inputs and the network was
re-trained. The performance error was observed. This process
was repeated for all the inputs shown in Fig. 1. Furthermore, it
is important to gain insight into the input variables, recognize
the pattern between them, and their level of correlation.
Therefore, clustering offers one unique approach to achieve
these. It is another excellent application of neural network,
though mostly used in unsupervised learning. In this study,
clustering was performed with a self-organizing map (SOM).
The SOM is the most commonly used type of neural network
for clustering. It has a competitive layer with neurons arranged
in a grid form and hexagonal topology. The SOM network is
trained with the input variables with each of them being con-
nected to each of the neurons using the weight vector. The input
data have been visualized in 2D using heatmap. Heatmaps
visualize data through setting variations in coloring. The
heatmap (weight planes/component planes) showing different
input variables is shown in Supplementary Fig. 1. Additionally,
the clustering of patients into two groups of either high- or low-
risk recurrence is given in Supplementary Fig. 2.
Implementation of the Web-based prognostic tool
The process of Web deployment using the Azure machine
learning Web application templates (Microsoft Corporation,
USA) involves two phases. The first phase is to develop a
predictive model using a machine learning studio. In the sec-
ond phase, the predictive model was then accessed and thus
set up as a Web service directly from Azure machine learning
studio. The Web tool for recurrence prediction can be freely
accessed on the Microsoft Azure cloud service [25]. Users of
this Web site can enter prognostic factors to generate a per-
sonalized estimation of locoregional recurrence for the patient.
The Web page is https://predictrecurrence.azurewebsites.net/
Default.aspx. We tested the accuracy of our Web-based prog-
nostic tool using 59 new cases of early OSCC treated between
1998 to 2008 at the UOPECCAN Cancer Hospital (Cascavel,
Parana, Brazil). These cases were included in our previous
study [28], but they were not included in the training of the
ANN and were not included in the development of our Web
page.
Results
The clinicopathologic characteristics of these patients have
been previously reported [19]. This cohort consists of 165
men and 146 women. The distribution of tumors according
to their diameter showed that 124 cases were staged T1 and
187 were T2. The number of patients with disease recurrences
was 89 (28.6%). All cases were clinically N0 and M0.
Similarly, the new cohort of 59 cases (46 men, 13 women)
differs from the first one of 311 cases used in the training. The
distribution according to tumor diameter showed that 22 pa-
tients had stage T1 and 37 stage T2. In terms of the distribu-
tion according to tumor budding, 14 patients showed no bud-
ding, 19 patients had less than five buds, and 26 patients had
five buds or more. The mean age at diagnosis within this
cohort was 56.2 (range 31–84). The number of patients with
a disease recurrence was 19 (32.2%) in this cohort that was
used to test the Web-based tool.
Our ANN model recognized tumor budding and depth of
invasion as the most important histopathological prognostic
parameters for the network to effectively predict locoregional
recurrence. The heatmap presented (Supplementary Fig. 1)
showed that the prognostic significance of input variables
were independent. Also, the SOM network appeared to have
clustered the patient into two distinct groups of high- and low-
risk recurrence (Supplementary Fig. 2). In terms of accuracy
of the network, the ANN yielded an overall accuracy of
92.7%. The accuracy of the ANN was higher than that given
by the logistic regression model which gave an accuracy of
86.5%. The receiving operating characteristic curve of the
network is given in Fig. 3. The error histogram of the training,
validation, and testing phases is shown in Fig. 4a.
An overall accuracy of 88.2% was obtained with the Web
prognostication tool. This was actually the overall proportion
of properly classified instances between the outputs and the
targets. Other metrics from the evaluation model included
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Fig. 2 The network training performance measure using cross-entropy
recall, precision, and area under receiving operating character-
istics curve (AUC). Recall, which is also known as sensitivity,
was 71.2% and specificity was 98.9%. The positive and neg-
ative predictive values were 97.7% and 84.5%, respectively.
The C-statistics (C-index) value was 97.3%. It is necessary to
mention that C-index equals to the area under the receiving
operating characteristics (ROC) curve shown in Fig. 4b. The
performance measures for both MATLAB and Azure Web
services are summarized in Table 2.
Testing/validation of the Web site with new cases
The Web site was tested with a new cohort of cases. Of the 59
cases tested, 48 cases were predicted correctly while 11 cases
gave incorrect predictions when compared with the actual
status of locoregional recurrence recorded by the hospital.
For this new cohort of cases, an 81.4% overall accuracy was
achieved using this Web-based tool. A sensitivity value of
78.9% was recorded indicating more than two thirds of the
cases under consideration. With this high value of sensitivity,
false-negative cases would be greatly reduced and would lead
to reduction in classification (prediction) error. The overall
performance metrics of the tested cohorts using our Web-
based prognostic tool is presented in Table 3.
Furthermore, a specificity value of 82.5% was achieved
with these test cases. In other words, the data from 33/40
patients with “low-risk” truly gave a prediction of “low-risk”
in the Web-based tool. A positive predictive value of 68.2%
was observed, pointing out the likelihood of a high-risk test
result in individuals who actually developed a recurrence.
Conversely, a negative predictive value of 89.2% was ob-
served. The latter value indicates the probability of a low-
risk result in the Web-based tool in individuals who are cases
of a true low risk for recurrence. Finally, from the
abovementioned performance information, a positive likeli-
hood ratio (LR+) of 4.5 and a negative likelihood ratio (LR−)
of 0.25 were computed. A LR+ indicates how much more
likely it is for the Web-based tool to predict a high risk for
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Fig. 3 The ROC curve of the trained network in MATLAB
recurrence compared to a low risk for recurrence. Similarly,
the LR− value indicates howmuch less likely it is for theWeb-
based tool to predict a low risk for recurrence.
Discussion
In this study, we explored the use of ANN to predict
locoregional recurrences in early-stage oral tongue cancer
and we reported a better performance for the ANN compared
with logistic regression. We also examined the odd ratios of
each of these prognostic parameters. In addition, we devel-
oped a Web-based tool that provides the prediction as “low-
risk” or “high-risk” of recurrence. The histopathologic param-
eters used in this study (and involved in our Web-based tool)
were selected based on findings in our previous study [19] and
our recent meta-analysis of many studies reporting the impor-
tance of tumor budding [20]. Depth of invasion and worst
pattern of invasion have also shown promising prognostic
significance in recent research by our group [7] and others
[29, 30]. Perineural invasion was a valuable marker in other
recent studies [8, 31]. In early OSCC, Arora et al. [21] have
recently introduced a prognostic model including all the his-
topathologic parameters that were included in our current
study. Of note, all histopathologic parameters included in this
study can be evaluated using routine hematoxylin and eosin
staining, and some of those parameters are routinely included
in pathology reports. Moreover, multivariate analyses of many
studies have underlined the prognostic significance of the se-
lected parameters [8, 19, 21, 29, 31].
This is the first study that used an ANN and provided a
Web tool for the prediction of recurrence in early-stage
OTSCC. A neural network seems to have the potential to offer
a better approach to data analyses and pattern recognition
within data. It can build a nonlinear statistical model to exam-
ine biological systems. There is no need to identify key prog-
nostic markers or to form a hypothesis in analyses using ANN.
Interestingly, the input variables were shown to be indepen-
dent of each other (Supplementary Fig. 1) as the connection
patterns of these inputs are dissimilar; hence, each of these
variables represents a different concept on the target variable.
Thus, the issue of collinearity inmachine learning is prevented
Table 2 The overall performance
measures of the network Software Performance measures for the training of the network
MATLAB 0.24471
Network performance error
92.7%
Accuracy
Azure Machine Learning (ML) Studio 88.2%
Accuracy
71.2%
Sensitivity
98.9%
Specificity
0.824
F1 Score
97.3%
C-index/AUC
97.7%
Positive predictive value (PPV)
84.5%
Negative predictive value (NPV)
494 Virchows Arch (2019) 475:489–497
Fig. 4 a Error histogram showing the difference between the targets and outputs. b An indicative receiver operating characteristics (ROC) curve from
Azure for the Web deployment
(no two input variables have the same effects on the target
variable). Therefore, a band of dark segments from the
lower-right region to the upper-right region demonstrate the
potential group associated with recurrence of OTSCC
(Supplementary Fig. 2).
While age of patient, tumor budding, depth, worst pattern
of invasion, and perineural invasion showed significant asso-
ciation in terms of odd ratios to the recurrence of OTSCC,
other parameters such as gender, clinical stage, histopatholog-
ical grade, lymphocytic host response, and follow-up time
showed low odd ratios but were included in the neural net-
work as confounders to report independence of the significant
markers and to improve the performance of ANN. Our study
assessed histopathologic parameters based on postoperative
surgical specimens. Therefore, patients that were recognized
as “high-risk cases” (according to our Web-based tool) might
benefit from postoperative adjuvant treatment (e.g., radiother-
apy). Of note, recent research has showed that some histopath-
ologic parameters (e.g., PNI, depth of invasion, and tumor
budding) that were included in our study can be evaluated
preoperatively either using magnetic resonance imaging [32]
or satisfactory diagnostic biopsies [20]. All these are addition-
al parameters to tumor grade, which is routinely reported for
preoperative biopsies. Thus, further research should consider
examining our Web-based tool in a large cohort with preop-
erative assessment of these histopathologic parameters. Such
approach has the potential of being of great importance for
treatment planning.
In the Microsoft Azure machine learning studio, a two-
class neural network algorithm was used to develop the
Web-based prognostic tool. It was able to produce reasonably
well true positive and false negative values in recurrence pre-
diction and had a high precision value of 97.7%. This value is
also known as the positive predictive value, which explains
the performance of our Web-based tool. The true positive and
false positive rates can be inspected in the receiving operating
characteristics (ROC) plot, also known as a precision/recall
plot, and the corresponding area under the ROC curve (Fig.
4b). In our study, the area under the characteristic curve was
97.3% with a curve that tends towards the upper left corner
(Fig. 4b) and far from the diagonal. This suggests a good
performance of the model. The values of the likelihood ratios
(LR+ 4.5/LR− 0.25) implied that our Web-based tool could
effectively predict the cases associated with or without a re-
currence of OTSCC.
This study also showed that the performance accuracy of
ANN was higher than the logistic regression model. Other
studies have compared ANN with traditional statistical
models. For example, the study by Faradmal et al. demonstrat-
ed that the ability of prediction with ANN was higher than
with the log-logistic regression model in predicting breast
cancer relapse [33]. Similarly, Kazemnejad et al. compared
ANN with binary logistic regression based on their perfor-
mance in differentiating between disease-free patients and pa-
tients with impaired glucose tolerance or diabetes mellitus
diagnosed by fasting plasma glucose [34].
In this study, the feedforward neural network produced a
better performance and predicted the recurrences reasonably
well by using enough neurons in the hidden layer. Computing
the performance of the network using cross-entropy ensures a
trained network that heavily penalizes outputs that are ex-
tremely inaccurate, with only little penalty for fairly correct
classifications. Thereby, it proved to be a network with good
classification capabilities. Hence, our findings indicated that
ANN is an effective approach for predicting recurrences in
early OTSCC. The Web-based tool provides the prediction
as “low-risk” or “high-risk” of recurrence. Thus, the decision
of multimodality treatment can be taken for those cases at high
risk although they are diagnosed at early stage.
It is important to mention that our Web-based tool was
trained with a limited number of cases. Therefore, it is possible
that it will miss some predictions. In addition, the values with-
in the follow-up time inmonths and disease-free time columns
are not sufficiently diverse. This means that prediction from
the Web-based tool for extremely high values of follow-up
time could not be relied upon. Accordingly, feedback from
users of this Web-based tool would be greatly appreciated. It
is also hoped that this tool would be re-trained at certain in-
tervals for better prediction based on the anticipated feedback
for better prediction capacity. In addition, our current neural
network did not include some parameters such as margin sta-
tus and pTNM stage due to unavailability of such information
Table 3 The performance of the Web-based tool on the newly tested cases
Patients with OTSCC
Web-based tool for the prediction
of OTSCC recurrences
High-risk OTSCC recurrences Low-risk OTSCC recurrences Total Other performance metrics
15
True positive
7
False positive
22
Total_Test-positive
68.2%
Positive predictive value (PPV)
4
False negative
33
True negative
37
Total_Test-negative
89.2%
Negative predictive value (NPV)
19
Total_High-risk OTSCC recurrences
40
Total_Low-risk OTSCC recurrences
59
Total_Test-cases
4.5/0.35
Positive/negative likelihood ratios
78.9%
Sensitivity
82.5%
Specificity
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for several cases in our multicenter cohort of six institutions.
Thus, we were not able to include these two parameters during
the construction of our neural network, and we advise includ-
ing such parameters in the further development of the neural
network of early OTSCC.
In conclusion, the use of ANN is an efficient means to
predict recurrence in early OTSCC. The combination of
markers that were presented in our Web-based tool were able
to predict recurrence successfully. With our Web-based tool,
patients could be identified as high or low-risk individuals,
which makes it easier to assess their prognoses. Those high-
risk cases were identified with aggressive histopathologic
characteristics (e.g., high intensity of tumor budding and deep
invasion). Thus, such cases might benefit from elective neck
dissection and postoperative oncological therapy in addition
to an individualized enhanced posttreatment follow-up pro-
gram. To further develop this Web-based tool, a multicenter
setting should be applied to add more data to improve its
effectiveness.
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